Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies : An UNLOCK Validation Study
Annemarije L Kruis,Björn Ställberg,Rupert Jones,Ioanna Tsiligianni,Karin Lisspers,Thys van der Molen,Janwillem W. H. Kocks,Niels H. Chavannes +7 more
Reads0
Chats0
TLDR
Primary care COPD patients stand out from patients enrolled in LPCS in terms of gender, lung function, quality of life and exacerbations, as hitherto unknown GOLD I exacerbation characteristics are revealed.Abstract:
Background: Guideline recommendations for chronic obstructive pulmonary disease (COPD) are based on the results of large pharmaceutically-sponsored COPD studies (LPCS). There is a paucity of data on disease characteristics at the primary care level, while the majority of COPD patients are treated in primary care. Objective: We aimed to evaluate the external validity of six LPCS (ISOLDE, TRISTAN, TORCH, UPLIFT, ECLIPSE, POET-COPD) on which current guidelines are based, in relation to primary care COPD patients, in order to inform future clinical practice guidelines and trials. Methods: Baseline data of seven primary care databases (n = 3508) from Europe were compared to baseline data of the LPCS. In addition, we examined the proportion of primary care patients eligible to participate in the LPCS, based on inclusion criteria. Results: Overall, patients included in the LPCS were younger (mean difference (MD)-2.4; p = 0.03), predominantly male (MD 12.4; p = 0.1) with worse lung function (FEV1% MD -16.4; p = 1 and >= 2 exacerbations, although results were not statistically significant. Our findings add to the literature, as we revealed hitherto unknown GOLD I exacerbation characteristics, showing 34% of mild patients had >= 1 exacerbations per year and 12% had >= 2 exacerbations per year. The proportion of primary care patients eligible for inclusion in LPCS ranged from 17% (TRISTAN) to 42% (ECLIPSE, UPLIFT). Conclusion: Primary care COPD patients stand out from patients enrolled in LPCS in terms of gender, lung function, quality of life and exacerbations. More research is needed to determine the effect of pharmacological treatment in mild to moderate patients. We encourage future guideline makers to involve primary care populations in their recommendations.read more
Citations
More filters
Journal Article
Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: A post-hoc analysis in the FLAME study 11 Medical and Health Sciences 1102 Cardi
Jadwiga A. Wedzicha,Dave Singh,Ioanna Tsiligianni,Christine Jenkins,Sebastian Fucile,Robert Fogel,Steven Shen,Pankaj Goyal,Karen Mezzi,Konstantinos Kostikas +9 more
TL;DR: The FLAME study as mentioned in this paper was a 52-week randomized controlled trial in patients with severe-to-very-severe COPD and a history of exacerbations, which included 2557 men and 805 women, with women being younger, having better lung function and more often experiencing ≥2 exacerbations in the previous year.
Asthma-COPD Overlap Syndrome : a review of current knowledge and future directions
TL;DR: Current definitions and concepts of the asthma COPD overlap syndrome are described and how the understanding of this syndrome may develop in the future is explored.
Journal ArticleDOI
Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial
Thomas Bradbury,Gian Luca Di Tanna,Anish Scaria,Allison Martin,Fuqiang Wen,Nanshan Zhong,Jinzhen Zheng,Peter J. Barnes,Bartolome R. Celli,Norbert Berend,Christine Jenkins +10 more
TL;DR: Combination low-dose theophylline and prednisone was associated with a significant increase in the annual moderate-severe exacerbation rate in participants with a blood eosinophil count ≥300 cells/µL compared to placebo.
Journal ArticleDOI
Détection précoce de la BPCO en soins primaires : un essai contrôlé randomisé
Anthony Chapron,F Pelé,E. Andres,Laure Fiquet,C Laforest,A Veislinger,C Fougerou,V Turmel,J Fouchard,B Yourish,S Oumari,Emmanuel Allory,A Banâtre,François-Xavier Schweyer,Jeanine Pommier,G. Brinchault,Stéphanie Guillot,Bruno Laviolle,Stéphane Jouneau +18 more
TL;DR: Cette etude confirme the faisabilite du protocole en soins primaires en termes de rapidite d’inclusions et d‘acceptabilite.
Journal ArticleDOI
Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study
Kjell Larsson,Karin Lisspers,Björn Ställberg,Gunnar Johansson,Florian S. Gutzwiller,Karen Mezzi,Bine Kjoeller Bjerregaard,Leif Jörgensen,Hyewon Koo,Christer Janson +9 more
TL;DR: The findings suggest that COPD constitutes a condition that influences health status even in mild disease clearly demanding an increased need for early detection and treatment.
References
More filters
Journal ArticleDOI
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo,Suzanne S. Hurd,Alvar Agusti,Paul W. Jones,Claus Vogelmeier,Antonio Anzueto,Peter J. Barnes,Leonardo M. Fabbri,Fernando J. Martinez,Masaharu Nishimura,Robert A. Stockley,Don D. Sin,Roberto Rodriguez-Roisin +12 more
TL;DR: It is recommended that spirometry is required for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation.
Journal ArticleDOI
Global initiative for chronic obstructive lung disease.
Lynn B. Gerald,William C. Bailey +1 more
TL;DR: Representatives from many countries serve as a network for the dissemination and implementation of programs for diagnosis, management, and prevention of COPD.
Journal ArticleDOI
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
Julie A. Anderson,Bartolome R. Celli,Gary T. Ferguson,Christine Jenkins,Paul W. Jones,Julie C. Yates,Jørgen Vestbo +6 more
TL;DR: The reduction in death from all causes among patients with COPD in the combination-therapy group did not reach the predetermined level of statistical significance, and there were significant benefits in all other outcomes among these patients.
Journal ArticleDOI
The St George's Respiratory Questionnaire.
TL;DR: The St George's Respiratory Questionnaire is a standardized self-completed questionnaire for measuring impaired health and perceived well-being in airways disease and the background and rationale for its development are discussed together with an analysis of its performance.
Journal ArticleDOI
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
John R. Hurst,Jørgen Vestbo,Jørgen Vestbo,Antonio Anzueto,Nicholas Locantore,Hana Müllerová,Ruth Tal-Singer,Bruce E. Miller,David A. Lomas,Alvar Agusti,William MacNee,Peter M.A. Calverley,Stephen I. Rennard,Emiel F.M. Wouters,Jadwiga A. Wedzicha +14 more
TL;DR: Although exacerbations become more frequent and more severe as COPD progresses, the rate at which they occur appears to reflect an independent susceptibility phenotype, which has implications for the targeting of exacerbation-prevention strategies across the spectrum of disease severity.